Speakers

Amy Pooler

Vice President, Neuroscience

Sangamo Therapeutics

Dominique Pichard

Chief Science Officer

International Rett Syndrome Foundation

Jacinthe Gingras

Director of Ophthalmology & Neuroscience

Homology Medicines

Jeffrey Kordower

Professor

Rush University Medical Center

John Pieracci

Director, Gene Therapy Process Development

Biogen

Juliette Hordeaux

Senior Director, Translational Research & Lysosomal Storage Disease

University of Pennsylvania

Junghae Suh

Vice President, Gene Therapy Accelerator Unit

Biogen

Krystof Bankiewicz

President & Chief Executive Officer

Brain Neurotherapy Bio, Inc.

Marie-Laure Nevoret

Senior Clinical Development Lead

REGENXBIO

Mark Milton

Ophthalmology Therapeutic Area Head, PK Sciences

Novartis

Martin Marsala

Professor

University of California, San Diego

Melissa Kotterman

Vice President, Vector Design

4D Molecular Therapeutics

Michael Linden

Chief Scientific Officer

Handl Therapeutics

Olivier Danos

Chief Scientific Officer

REGENXBIO

Petra Kaufmann

Senior Vice President, Clinical Development & Translational Medicine

AveXis

R. Jude Samulski

Chief Scientific Officer

AskBio

Ronald Crystal

Chairman, Department of Genetic Medicine

Weill Cornell Medicine

Smitha Jagadish

Lab Head

Sanofi

Jackie Glascock

Director, Research Programs

CureSMA

Grace Liang

Executive Medical Director

Neurocrine Biosciences

Holger Patzke

Vice President, Neuroscience

Voyager Therapeutics

Steven Gray

Associate Professor

University of Texas Southwestern Medical Center

Vanessa Almendro

Head of Strategy & External Innovation

Eisai Center for Genetics Guided Dementia Discovery (G2D2)

Mark Tuszynski

Director, UCSD Translational Neurosciences Institute; Distinguished Professor of Neurosciences

University of California - San Diego

Mark Souweidane

Vice Chairman of Neurological Surgery & Director of Pediatric Neurological Surgery

Weill Cornell Medical College

Phillip Maples

Vice President, Process Development

Abeona Therapeutics, Inc.

Enrique Rodriguez

Head of Study Directors

Charles River

Patrick Trapa

Distinguished Investigator

Biogen

J Fraser Wright

Professor of Pediatrics

Center for Definitive & Curative Medicine, Stanford University School of Medicine

Piet van der Graaf

Senior Vice President of QSP

Certara

Hemi Dimant

Director of Applications for Advanced Pathology Services (APS)

Invicro

Lisa Spronck

Non-Clinical Development Scientist

UniQure

Ralph Laufer

Chief Scientific Officer

Lysogene